Catalyst Watch: Eyes on Tech With Apple, Amazon, Alphabet, and Meta Reporting

Seeking Alpha03:00

Marinus Pharmaceuticals Price Target Cut to $1.00/Share From $3.00 by RBC Capital

Dow Jones01:37 · Ratings

Cantor Fitzgerald Maintains Overweight on Marinus Pharma, Lowers Price Target to $4

Benzinga00:16 · Ratings

Oppenheimer Maintains Marinus Pharmaceuticals(MRNS.US) With Buy Rating

Futu NewsOct 25 21:31 · Ratings

Marinus Downgraded After Setback to Late-stage Trial

Seeking AlphaOct 25 21:05 · Ratings

A Quick Look at Today's Ratings for Marinus Pharmaceuticals(MRNS.US), With a Forecast Between $3 to $3

Futu NewsOct 25 21:00 · Ratings